Answers are grounded in this paper and cite their sources.
Background: In relation to diabetic nephropathy, a leading cause of chronic kidney disease worldwide, chronic inflammation is a major contributor to its development. Unfortunately, conventional kidney markers do not pick up on the very early stages of inflammation, and this is where Neutrophil–Lymphocyte Ratio, or NLR and Platelet–Lymphocyte Ratio, or PLR, step in. Coming from regular blood tests, these two markers have been found to be simple and affordable ways to monitor the degree of inflammation. Aim: To find out how NLR and PLR are related to the progression of diabetic nephropathy in people with type 2 diabetes mellitus in South India. Materials and Methods: Looking at 90 patients with type 2 diabetes, this study sorted them into three groups based on their Urine Albumin-Creatinine Ratio, or UACR. They found that the 30 patients in the normoalbuminuria group, the 30 in the microalbuminuria group and the 30 in the macroalbuminuria group all had different clinical profiles. Glycemic status, renal function, and complete blood counts were also examined. NLR and PLR were calculated, and looked at in relation to renal function. The statistical analysis consisted of Analysis of Variance, Pearson correlation, receiver operating characteristic curve analysis and multivariate logistic regression. Results: When looking at the progression of albuminuria, both the NLR and PLR saw significant increases, but with NLR having a much stronger correlation to the UACR ( r = 0.782, P < 0.001) and serum creatinine levels ( r = 0.721, P < 0.001). It also had a negative correlation with estimated Glomerular Filtration Rate, r = −0.789, P < 0.001. The diagnostic accuracy of NLR was found to be better, as indicated by a higher Area Under the Curve (AUC) of 0.86, compared to PLR with an AUC of 0.74. On multivariate analysis, NLR was found to be an independent predictor of diabetic nephropathy, odds ratio =3.45, 95% confidence interval: 2.12–5.67, but PLR did not show any independent association. Conclusion: Concerning diabetic nephropathy, NLR, has proven to be a more effective marker for the disease than PLR. Coming in at a relatively low cost and requiring no special equipment, NLR’s superior correlation with diabetic nephropathy severity could make it a valuable screening tool for the early detection of kidney disease in type 2 diabetes patients. Integrating NLR into regular clinical care would allow doctors to identify which patients are more at risk of renal complications, and potentially put them on a more rigorous treatment and monitoring plan.
No takes yet. Share an insight, caveat, or question.
Reddy et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: